Recent Company News

• 08:44 AM ET May 29, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:17 PM ET May 28, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:27 PM ET May 28, 2026
  

  Hutchmed upgraded to equal-weight from underweight at Morgan Stanley (HK$17.79, 0.00)

• 10:00 AM ET May 28, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (97 total)

• 03:33 AM ET May 28, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (57 total)

• 11:12 PM ET May 27, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (209 total)

• 03:32 AM ET May 27, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (43 total)

• 03:34 AM ET May 26, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (56 total)

• 11:37 PM ET May 25, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (232 total)

• 08:04 PM ET May 21, 2026
  

  HUTCHMED to present savolitinib phase II gastric/GEJ MET amp data at ASCO 2026 (HK$18.87, 0.00)